LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Strona główna・Stock List・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Closed

SectorHealthcare

8.84 -14.34

Buy Sell

Overview

Share price change

24h

Current

Min

8.67

Max

9.99

Key metrics
By Trading Economics
Income	11M -20M
Sales	5.9M 40M
EPS	-0.19
Profit margin	-49.569
Employees	184
EBITDA	16M -19M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+138.59% upside

Market Stats
By TradingEconomics
Market Cap	294M 1B
Previous open	23.18
Previous close	8.84

News Sentiment

By Acuity

50%

171 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

6.26 / 7.47 Support & Resistance

Day One Biopharmaceuticals Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 lis 2025, 21:34 UTC

Earnings

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 lis 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 lis 2025, 23:42 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 lis 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 lis 2025, 23:24 UTC

Earnings

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 lis 2025, 23:24 UTC

Earnings

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 lis 2025, 23:23 UTC

Earnings

JBS NV 3Q EPS 52c >JBS

13 lis 2025, 23:23 UTC

Earnings

JBS NV 3Q Sales $22.6B >JBS

13 lis 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 lis 2025, 22:02 UTC

Earnings

Nu Holdings 3Q Net $783M >NU

13 lis 2025, 22:01 UTC

Earnings

Nu Holdings 3Q Rev $4.2B >NU

13 lis 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 lis 2025, 21:50 UTC

Earnings

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 lis 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 lis 2025, 21:41 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 lis 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 lis 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 lis 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 lis 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 lis 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 lis 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 lis 2025, 21:33 UTC

Earnings

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 lis 2025, 21:31 UTC

Earnings

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 lis 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 lis 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q EPS 34c >FIGR

13 lis 2025, 21:23 UTC

Earnings

Intchains Group 3Q Rev $1.3M >ICG

13 lis 2025, 21:03 UTC

Earnings

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 lis 2025, 21:02 UTC

Earnings

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 lis 2025, 21:01 UTC

Earnings

Applied Materials 4Q Rev $6.8B >AMAT

13 lis 2025, 21:01 UTC

Earnings

Applied Materials 4Q Gross Margin 48.0% >AMAT

Peer Comparison

Price change

Day One Biopharmaceuticals Inc Forecast

Price Target

By TipRanks

138.59% upside

12 Months Forecast

Average 24.67 USD 138.59%

High 34 USD

Low 16 USD

Based on 8 Wall Street analysts offering 12 month price targets forDay One Biopharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Day One Biopharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

6.26 / 7.47Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

171 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.